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Abstract
Cancer patients treated with radiotherapy (RT) could develop severe late side effects that affect their quality of life. Long-term
bowel complications after RT are mainly characterized by a transmural fibrosis that could lead to intestinal obstruction. Today,
surgical resection is the only effective treatment. However, preoperative RT increases the risk of anastomotic leakage. In this
study, we attempted to use mesenchymal stromal cells from adipose tissue (Ad-MSCs) to improve colonic anastomosis after
high-dose irradiation. MSCs were isolated from the subcutaneous fat of rats, amplified in vitro, and characterized by flow
cytometry. An animal model of late radiation side effects was induced by local irradiation of the colon. Colonic anastomosis was
performed 4 wk after irradiation. It was analyzed another 4 wk later (i.e., 8 wk after irradiation). The Ad-MSC-treated group
received injections several times before and after the surgical procedure. The therapeutic benefit of the Ad-MSC treatment was
determined by colonoscopy and histology. The inflammatory process was investigated using Fluorine-182-Fluoro-2-Deoxy-d-
Glucose Positron Emission Tomography and Computed Tomography (18F-FDG-PET/CT) imaging and macrophage infiltrate
analyses. Vascular density was assessed using immunohistochemistry. Results show that Ad-MSC treatment reduces ulcer size,
increases mucosal vascular density, and limits hemorrhage. We also determined that 1 Ad-MSC injection limits the inflammatory
process, as evaluated through 18F-FDG-PET-CT (at 4 wk), with a greater proportion of type 2 macrophages after iterative cell
injections (8 wk). In conclusion, Ad-MSC injections promote anastomotic healing in an irradiated colon through enhanced vessel
formation and reduced inflammation. This study also determined parameters that could be improved in further investigations.
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Introduction
Radiotherapy (RT) is used in at least 50% of cancer patients
and approximately 25% of solid tumors undergo complete
remission after RT.1 Abdominal or pelvic RT is commonly
accepted as a neoadjuvant, central adjuvant, or even pallia-
tive therapy in the treatment programs of colorectal,2,3 uro-
logical,4 and gynecological tumors. Healthy regions of the
small intestine, colon, and rectum inevitably lie within the
field of irradiation used to treat tumors in the abdominal or
pelvic cavity. These healthy tissues are thus at risk of severe
damage. Intestinal radiation toxicity is a complex and
dynamic process involving stem cell depletion, endothelial
cell activation, and chronic inflammation associated with
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persistent oxidative stress, contributing to tissue fibrosis and
leading to structural and functional alterations.5 Chronic side
effects are described in 5% and 10% of the patients treated
by pelvic RT 5 and 10 years, respectively, after the end of
their cancer treatment, and they are the cause of substantial
long-term morbidity.6 Despite the significant increase in
cancer patient survival due to RT, radiation toxicity of nor-
mal tissue surrounding the tumor is clearly identified as a
high-risk factor for postoperative complications,7,8 including
impaired bowel anastomotic healing. Preoperative RT is
considered to be a risk factor for esophageal8 and rectal9–11
anastomotic healing. In the case of colorectal cancer as well as
benign conditions or anomalies like diverticulitis or duplica-
tion cysts, anastomotic leakage during curative resection is
still considered a major clinical problem since it is associated
with high rates of morbidity and mortality. In the literature of
the past 25 years, reported mortality has been as high as
33%.12 The most important factor involved in anastomotic
leakage is abnormal blood supply. Hypoxia could interfere
with tissue viability, leading to tissue necrosis and, conse-
quently, delayed healing. Ischemic wounds heal poorly and
infect easily, exacerbating mucosal inflammation. Optimi-
zation of the healing processes is a central topic in surgical
research. Attempts to enhance anastomotic healing
included improvements in surgical techniques, various
innovative sealing procedures, and use of various growth
factors to stimulate the healing process.13 However, the
benefits of these treatments have not been tested in high-
risk anastomoses, as during sepsis or after irradiation.
Recent studies conclude that radiation therapy is an inde-
pendent risk factor for anastomotic leakage.14 Acute color-
ectal radiation toxicity (within 3 mo) is the result of crypt
cell apoptosis leading to mucosal lesions with loss of
epithelial barrier function. The increased mucosal perme-
ability leads to nutrient and fluid loss and increased gut
pathogen infiltration, exacerbating mucosal inflammation.
Increased vascular permeability also contributes to infiltra-
tion of the injured mucosa by immune cells, mainly neu-
trophils and macrophages.15 Delayed radiation colopathy is
more complex, irreversible, often progressive, and charac-
terized by mucosal atrophy, fibrosis of the colon wall, and
microvascular sclerosis.16 It is now recognized that the
pathophysiology is not adequately explained by the target
theory, where only the epithelium was thought to be
responsible for acute toxicity, and both fibroblasts and
endothelial cells for delayed toxicity. Enteric neuroimmune
interactions, the colonic microbiota and microvasculature,
composition of intraluminal contents, stem cell loss, and
other factors are also involved in toxicity pathways. Ana-
stomosis in an irradiated colon involves colonic wound
healing and radio-induced inflammatory processes, fibro-
sis, and damage to the vascular network. Consequently,
there is thought to be a high risk of leakage. In some
patients, functional complications associated with the anat-
omy of the colon and rectum make it impossible to com-
pletely remove the irradiated area.
Adult mesenchymal stromal cells (MSCs) are self-
renewing, easily expandable progenitor/stem cells. Their
therapeutic effects in various diseases have been
reported,17–23 suggesting a potential use for MSCs in regen-
erative medicine and tissue engineering. Preclinical studies
have demonstrated that MSCs have the capacity to enhance
self-renewal of small intestinal and colonic epithelium24–27
and accelerate structural recovery after radiation injury.28,29
A body of evidence shows that the therapeutic benefit of
MSCs is induced by the secretion of bioactive mole-
cules.30,31 MSCs have immunomodulatory properties
involving low immunogenicity, the ability to modify the
maturation and function of antigen-presenting cells, and an
alteration in the cytokine secretion of inflammatory cells.
Two experimental studies demonstrated the ability of MSCs
to enhance healing after colonic anastomosis.32,33 Moreover,
a previous study showed an improvement in cutaneous blood
supply following cutaneous irradiation.34 Various sources of
MSCs have emerged. MSCs from adipose tissue (Ad-MSCs)
are abundant, and they are easy to harvest and expand in
vitro. These properties make Ad-MSCs an autologous cell
source that may, in some cases, be valuable for regenerative
cell therapy. In this study, we aimed to evaluate the thera-
peutic benefits of Ad-MSC injections in an experimental rat
model of irradiated colonic anastomosis. Mucosal wound
healing and inflammatory processes were investigated.
Materials and Methods
Animals, Irradiation, and Sample Collection
All experiments were performed in compliance with the
Guide for the Care and Use of Laboratory Animals as pub-
lished by the French regulations for animal experiments
(Ministry of Agriculture Order No. B92-032-01, 2006) with
European Directives (86/609/CEE) and were approved by
local ethical committee of the institute of Radioprotection
and Nuclear Safety in Fontenay-aux-Roses (P12-04) and
Ghent University Hospital (EC: EDC 12/03). Forty-eight
Sprague-Dawley (SD) rats (9 wk-old male rats of 300 to
350 g) were purchased from Charles River Laboratories
(L’Abresle, France). Rats submitted to RT were anesthetized
by isoflurane inhalation, and a single 27 Gray (Gy) dose was
delivered by 60Co source through a 2  3 cm window cen-
tered on the colorectal region. All rats were marked by ear
puncture. On the day of euthanasia, animals were anesthe-
tized by isoflurane inhalation; blood samples were taken
under cardiac puncture, and the colon was collected for his-
tological examination and fixed in 4% formaldehyde.
Study Design and Administration of Ad-MSCs
The design of the protocol is described in Fig. 1. The study
compared 3 groups that all underwent colonic anastomosis.
For group 1, the control/sham group, anastomosis was per-
formed 4 wk after sham irradiation. For group 2, anastomosis
was performed 4 wk after irradiation. The same volume of
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phosphate buffered saline (PBS) 1was injected at the same
time as for group 3 but without Ad-MSCs. Group 3 was
irradiated and received Ad-MSC treatment. In this group, 3
wk after radiation exposure, 5  106 Ad-MSCs in 500 mL of
PBS 1 were infused into the tail vein. Surgery was per-
formed 1 wk later (i.e., 4 wk after irradiation). During sur-
gery, Ad-MSCs (5  106 in 300 mL of PBS 1) were
injected locally at 2 injection sites on both edges of the
dissected colon before performing anastomosis. Every 10
d, 2 more intravenous injections of 5  106 Ad-MSCs were
performed. During the study, 2 18F-FDG-PET-CT analyses
were performed for each rat (1 d before surgery, i.e., at 4 wk,
and 1 d before euthanasia, i.e., at 8 wk). Colonoscopies were
performed on all groups before euthanasia (8 wk). All groups
were euthanized after 8 wk (study protocol, Fig. 1). For all
procedures requiring immobilization, animals were anesthe-
tized by isoflurane inhalation.
Ad-MSC Culture and Characterization
Subcutaneous inguinal adipose tissue was removed from SD
rats, finely minced, and enzymatically digested at 37 C in
minimum essential media (MEM) containing 0.1% collage-
nase type I (Sigma-Aldrich, St Quentin Fallavier, France) for
30 min (min), 3 times. The digested tissue was filtered
through a 100 mm filter. Collagenase was then neutralized
with culture medium containing 10% fetal bovine serum
(FBS). After centrifugation (1200 rpm for 3 min), cells were
suspended in MEMa containing 20% FBS, penicillin–
streptomycin and L-glutamin (all from Invitrogen) plated at
1000 cells by cm2 and cultured at 37 C in humidified 5%
CO2. After 6 d, the monolayer of adherent cells was trypsi-
nized, washed in PBS 1 3 times before injection in rats.
The phenotype of amplified Ad-MSCs was verified by flow
cytometry. The percentage of CD90 (clone OX-7; BD Bios-
ciences) andCD73 (clone5F/B9;BDBiosciences) positive cells
were analyzed, and the absence of hematopoietic cells was ver-
ifiedwithCD34 (clone ICO115, SantaCruzBiotechnology) and
CD45 (clone OX-1; BDBiosciences) markers. Isotype identical
antibodies served as controls.
Surgery
Surgery was performed under general inhalation anesthesia
induced with 5% isoflurane. The anesthesia was evaluated
by reaction on leg pressure and respiration frequency and
continued in a steady state with 1.5-2% isoflurane. The rat
was fixed in dorsal decubitus under sterile conditions on a
heated operation table. The abdomen of the rat was shaved
just before surgery and disinfected with povidone iodine. A
distal midline laparotomy of 3 to 4 cm was performed. Sharp
dissection was used, without electronic or ultrasonic coagu-
lation devices. The distal colon and rectum with the hip as
the lowest border were the regions of interest. The cecum
and the small bowel were protected and kept out of the
operation field with a moist gauze. The abdominal wall and
the colon were exposed by 2 traction points. In the irradiated
groups, the colon was cut in the center or just above the
Figure 1. Scheme of the experimental procedure. Rats received local irradiation of the colon. Three weeks after irradiation, a first intravenous
injection of mesenchymal stromal cells (MSCs) was administered. At 4 wk, before the colonic anastomosis, a positron emission tomography–
computed tomography (PET-CT) scan was performed. During the surgical procedure, MSCs were injected locally in the mucosa, after
resection, on both sides of the colon. Then, 2 intravenous injections of MSCs were administered (approximately every 10 d). At 8 wk, the
rats were submitted to PET-CT scan analyses and colonoscopy. Animals were euthanized, and tissues were collected for histological analyses.
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irradiated area (white and nonvascularized area). Ad-MSCs
or PBS 1 were locally injected at 2 injection sites on both
edges of the dissected colon. The anastomosis was realized
at 4 cm from the rectum and above the pelvic bone. The
colon was sutured end to end with interrupted polydioxanone
stitches (PDS1 6/0) with all the knots outside, each 2 mm.
The abdomen was closed with polyglactin 910 (Vicryl1 3/
0) running suture and the skin with polyglecaprone (Mono-
cryl1 4/0) intracutaneously. Analgesia (Temgesic1 0.03
mg (/mL solution)/kg) was subcutaneously injected.
Positron Emission Tomography–Computed
Tomography (18F-FDG-PET-CT)
All animals were food deprived for at least 6 h prior to 18F-
FDG-PET-CT imaging. During the study, 2 18F-FDG-PET-
CT scans were performed in each animal (Fig. 1). Rats were
anesthetized with an isoflurane mixture (2-5% isoflurane and
medical O2) to insert a catheter in 1 of the tail veins for
intravenous injection of 19.9+ 0.7 MBq of [18F]FDG (Ghent
University Hospital, Nuclear Medicine Department, Belgium)
dissolved in 200 mL of saline. Next, the animals were posi-
tioned on the heated animal bed of a small animal dedicated
PET scanner (FLEX Triumph II; TriFoil Imaging1, North-
ridge, CA, USA) and 0.8 mL gastrografin was administered
rectally, directly followed by a CT scan acquired for coregis-
tration purposes. Animals were placed in the center of the
field of view in a prone position, receiving further anesthesia
through a nose cone. Body temperature was maintained at
*37 C by the heated bed. CT projection data were acquired
using the following parameters: 256 projections, detector
pixel size 50 mm, focal spot size 100 mm, tube voltage 75
kV, tube current 500 mA, and a field of view of 90 mm. Thirty
minutes after tracer injection, a 30-min PET scan was
acquired in list mode, with a 75-mm axial field of view and
a 1.3-mm spatial resolution, on the same scanner and without
moving the animal. CT images were analytically recon-
structed using a filtered back projection reconstruction algo-
rithm (Cobra Version 7.3.4; Exxim Computing Corporation,
Pleasanton, CA, USA) into a 512  512  512 matrix with
250 mm isotropic voxel size. The acquired PET images were
reconstructed into a 200  200  64 matrix by a 2D maxi-
mum likelihood expectation maximization algorithm (Lab-
PET Version 1.12.1; TriFoil Imaging) using 50 iterations
and a voxel size of 0.5  0.5  1.175 mm3 (x, y, z). Each
resultant CT image is inherently coregistered with the corre-
sponding PET scan. PET and CT images were imported into a
medical image data examiner and volumes of interest, deter-
mined on sagittal, coronal, and transversal reconstructed CT
slices, were drawn over the colon to quantify the uptake of
[18F]FDG in the colon, expressed in MBq/mL.35
Endoscopy and Scoring Methods
Colonoscopic analyses were performed at 8 wk after RT on
anesthetized rats with a pediatric bronchoscope (Pentax,
France, Argenteuil). Colonic anastomotic healing was
observed and scored as described in Supplemental Fig. 1.
Histological Analyses and Healing Assessment Method
Colon specimens were embedded in paraffin, cut into 5 mm
sections, and stained with hematoxylin–eosin–saffron. His-
tological sections of normal colon showed organized and
aligned crypts. In the irradiated and operated segment, 2
areas were identified: an ulcerated area without any crypts
and a dystrophic area composed of atypical crypts. The size
of each area was measured as designed in Fig. 2A, using
Histolab software, v10.6.0 (MicroVision Inc., Redmond,
WA, USA).
Immunostaining Analyses
For immunohistochemistry analyses of vessels, sections were
dewaxed then placed in an antigen retrieval solution (0.01 M
citrate buffer, pH¼ 6 [DakoCytomation, Trappes, France] for
3  5 min at 350 W). The endogenous peroxidases were
inhibited by incubation with 3% H2O2 in methanol at room
temperature (RT) for 10 min. After saturation (X0909; Dako-
Cytomation), rabbit antirat von Willebrand factor (vWF)
diluted at 350e (Abcam, Paris, France) was applied to the
section for 1 h at 37 C. Staining was developed with Histo-
green substrate (E109; Abcys), and sections were counter-
stained with nuclear fast red (S1963; DakoCytomation,
Trappes, France), dehydrated and mounted. Isotype control
antibodies are used as negative controls. The number of vas-
cular sections (vWF positive) was numbered on defined sur-
face using a Leica microscope (Nanterre, France) and
Histolab software (MicroVision Inc.,). For CD68 and
CD163 coimmunostaining (macrophage analyses), tissue sec-
tions were treated with proteinase K (DakoCytomation) at RT
for 5 min and quenched for endogenous peroxidases as
described above. After saturation, mouse antirat CD68 (AbD
Serotec, Biorad, Marnes-la-coquette, France) or mouse antirat
CD163 (AbDserotec, Peterborough, UK) was applied to the
section for 1 h at 37 C. Tissue sections were incubated with
goat antimouse Alexa fluor 568 (Invitrogen) and with donkey
antimouse Alexa fluor 488 (Invitrogen), respectively, for 30
min at RT. The tissue sections weremounted with Vectashield
hard-set (Vector Laboratories) and visualized under a fluor-
escence confocal microscope (LSM 780; Carl Zeiss, Iena,
Germany). The double staining was evaluated using Zen1
software, version 2012.
Statistical Analyses
All data are presented as mean +standard error of mean.
Statistical analyses were performed using Sigma plot V11.0
(Systat Software, Erkrath, Germany). Differences between
groups were analyzed using the unpaired student t test or
nonparametric Mann–Whitney test when necessary. P <
0.05 was considered to indicate statistical significance.
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Results
Ad-MSC Phenotype and Differentiation
Cells isolated from adipose tissue were plated under specific
culture conditions. They exhibited homogenous spindle-
shaped morphology (Fig. 3A). The capacity to form
colony-forming units was evaluated: there were 62.06 (+
4.46) for 1000 cells seeded in 25 cm2 (Fig. 3B). The Ad-
MSC phenotype was analyzed for stromal characteristics by
flow cytometry at passages 0 and 1. The cells expressed high
levels of CD90, CD73, and CD29, and they were negative
for hematopoietic markers (Fig. 3C). On average, Ad-MSCs
expressed CD90 at 96.6% (+ 0.19%), CD73 at 100%, CD29
at 100%, CD34 at 0.1% (+0.06%), and CD45 at 0.5% (+
0.19%).
General Results
The study was divided into 4 series of 3 groups of rats: sham
(group 1, or G1), irradiated (G2), and both irradiated and
treated with Ad-MSCs (G3). In the first 2 series, almost all the
irradiated rats died, whether they were treated with Ad-MSCs
(8 of 8) or not (7 of 8). Deaths always occurred 5 to 10 d after
surgery. All rats of the sham groups survived (7 of 7). We
concluded that the surgical technique alone was not the prob-
lem, but rather the combination of surgery and irradiation.
Perioperative examination and autopsy showed that the
level of irradiation was too low in the pelvis, leading to
traction during surgery and tissue tearing. All autopsies
revealed no perforation but extensive in a frozen pelvis.
In the subsequent 2 series, the field of radiation was
applied more proximally to the colon, and the colon
was cut immediately above the irradiated area (G1, n
¼ 4; G2 and G3, n ¼ 10). This change in technique
improved survival in the irradiated groups (Fig. 4A).
In terms of weight changes, no significant difference
was observed between the irradiated groups (Fig. 4B).
Macroscopic Evaluation of Ad-MSC Treatment for
Colonic Anastomosis After Irradiation
Before euthanasia, colonic damage was evaluated using
endoscopy (Fig. 5A). Details on scoring (Fig. 5B) are given
in Supplemental Figure 1. In G1 (sham), we observed com-
plete healing following colonic anastomosis, together with
a great number of vessels. In G2 (irradiated), colonic anasto-
mosiswas associatedwith a large amount of necrotic tissue and
fibrin, as revealed by white and brown deposits. In G3
Figure 2. Characterization of MSCs before injection. (a) Morphology of the Ad-MSCs in culture before injection (b) Representative picture
of colony-forming unit-fibroblast (CFU-F) assay stained with crystal violet. The CFU-F assay has been used to enumerate the number of
Ad-MSCs within the initial cell preparation. (c) Flow cytometry analysis of MSCs before injection. MSCs expressed high levels of CD90,
CD73 and CD29 specific markers (upper panel). MSCs did not express hematopoietic marker as CD34 and CD45 (lower panel).
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(irradiated and treated with Ad-MSCs), we observed fewer
necrotic patches around the anastomosis than in G2. However,
the treatment did not allow complete healing, which was
observed in G1. We also evaluated the amount of bleeding
during colonoscopy (Fig. 5B). After irradiation and surgery,
colonoscopy triggeredhemorrhaging in>57% of all rats. InG1,
however, bleeding was found in only 1 (14.3%) rat.
Assessment of Ad-MSC Therapeutic Benefit on Colonic
Healing Using Histological Criteria
The rats were sacrificed 8 wk postirradiation, and anastomo-
tic healing was assessed by measuring the size of the colonic
scar (i.e., area without crypt and ulcer) and atypical mucosa
(i.e., area with disorganized crypts; Fig. 2A). We observed
that the size of the atypical area was not modified, regardless
of whether rats were administered Ad-MSC treatment. How-
ever, the ulcerated area was statistically smaller after treat-
ment with Ad-MSCs (P < 0.05; Fig. 2B).
We also counted, on histological slides, vascular sections
of the anastomosis for each group of animals. Irradiation (G2
and G3) reduced the number of vascular sections compared
to the sham treatment (G1). Furthermore, the number of
vascular sections was normalized in animals that received
Ad-MSC treatment (Fig. 2C).
Analyses of Inflammatory Process Using Noninvasive
PET/CT and Immunohistochemistry
Radioactive tracer was injected intravenously, and 30 min
later images were acquired by PET scan (Fig. 6A), CT
images were analyzed, and results were expressed as means
in Becquerels (Bq; Fig. 6B). In G1, PET scans were per-
formed before the surgery, determining the basal metabolic
level (control). Inflammatory response in G1 4 wk after
colonic anastomosis (i.e., at 8 wk), the metabolic activity
was not significantly increased; thus, no substantial inflam-
matory response could be attributed to anastomosis 4 wk
after the operation. However, in the irradiated group, 4 wk
after colonic irradiation (before surgery), the mean of meta-
bolic activity was increased by 65% compared to G1. The
study design allowed us to consider the effect of 1 intravenous
Ad-MSC injection on the inflammatory process 4 wk after
irradiation. The results demonstrated that inflammation in
G2 was significantly greater than in G1 (P ¼ 0.03), whereas
greater inflammation in G3 was not significant (P ¼ 0.16).
We noted that Ad-MSCs induced a 21.1% reduction in
inflammation 7 d after treatment. However, the lower degree
of inflammation observed in G3 with respect to G2 at 8 wk,
measured as means in Becquerels, was not significant.
To extend our analysis of the therapeutic effects of
Ad-MSCs on the inflammatory process, we studied macro-
phage infiltrates on histological slides, 8 wk after irradiation.
Macrophage subpopulations are addressed in the literature,
and the M2 subpopulation in particular has been described
as a key player in the wound healing process.36 Using double
immunolabeling (CD163 and CD68), we determined M2 pro-
portions for the different groups (Fig. 7). In G1, we found few
M2 macrophages in the colonic lamina propria. As expected,
after irradiation and surgery (G2), the total number of macro-
phages greatly increased. In G3, the proportion of M2 macro-
phages (CD163CD68 costaining) in the total CD68-stained cell
population was 49.3%. The M2 percentage had risen (Fig. 7).
Discussion
Anastomotic dehiscence is one of the most serious potential
complications of colorectal surgery. An understanding of the
normal healing process for wounds, in general, and surgical
wounds or anastomoses, in particular, is essential for the treat-
ment of anastomotic leakage. Although such healing has long
been studied, it is still not completely understood. Described
in phases defined according to time elapsed since injury,37 it is
a dynamic, interactive process involving blood cells, parench-
ymal cells, soluble mediators, and the extracellular matrix.
The first phase is hemostasis. This starts immediately and is
characterized by vasoconstriction, initiation of the coagulation
cascade, and platelet activation,38 and resulting in a fibrin/
fibronectin matrix that temporarily seals and connects the 2
Figure 3. (A) Rat survival according to localization of the colonic
anastomosis. For lower anastomosis, n ¼ 8 animals for each group.
For higher anastomosis, n ¼ 4 animals for group 1 and n ¼ 10
animals for groups 2 and 3. (B) Body weight of animals was mon-
itored at 4 and 8 wk (n ¼ 4 animals for group 1 and n ¼ 10 animals
for groups 2 and 3).
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bowel ends. The inflammatory phase is next: vessels dilate
and become more permeable. Phagocytosis of damaged tissue
involves neutrophils first and macrophages later.39 Both cell
types produce inflammatory cytokines, including tumor
necrosis factor a (TNF-a), interleukin 1 (IL-1), and proteases.
Macrophages also secrete transforming growth factor b
(TGFb), TGFa, and platelet-derived growth factor (PDGF),
modulating fibroblast activity as well as the inflammatory
response, reepithelialization, and angiogenesis. They thus
play an important role in wound healing. The proliferative
phase, which overlaps with the inflammatory phase, involves
deposition of collagen and formation of new extracellular
matrix. At the same time, angiogenesis is initiatedwhen tissues
secrete vascular endothelial growth factor (VEGF), which
directly triggers the proliferation of endothelial and smooth
muscle cells. The mucosa is also regenerated by epithelial cell
hyperplasia and migration. During the final remodeling or
maturation phase, collagen homeostasis is achieved and
marked by changes in types of collagen as well as an increase
in tensile strength through cross-linking of collagen fibers.
As the colon harbors the densest bacterial population,
operative procedures involving resection and anastomosis
of the colon are associated with higher rates of surgical
site infection or leakage. Several risk factors for anastomo-
tic leakage have been identified. They include certain
patient profiles and the use of neoadjuvant RT as well as
particular drugs, like steroids. Several studies on sealing or
reinforcement have been completed or are ongoing. Fibrin
glue has no effect, and other tissue adhesives or pharmaco-
logical interventions are not effective or need further inves-
tigations.9,13,40–43 The persistence of foreign antigens or
dense bacterial colonization of the wound site can lead to
a prolonged inflammatory response. This is marked by the
continued presence of innate immune cells releasing high
amounts of protease and reactive oxygen species that may
also damage the extracellular matrix. The use of preventive
systemic antibiotics perioperatively has become a standard
of care.44 Mechanical bowel preparation continues to be a
controversial subject. When followed by treatment with
appropriate oral antibiotics, it has been reported to reduce
surgical site infections.45 The healing process thus
described inevitably depends on adequate vascular supply
and oxygenation. Ischemia in tissue surrounding the site of
anastomosis is one cause of anastomotic leakage having a
major impact on wound healing. Though chemical agents
have been introduced, in particular a molecule that
enhances vasodilatation by smooth muscle relaxation in the
vessels, observed effects have not been promising.32,46
Stem cell research has received much attention in recent
years and their use has been shown to have beneficial effects.
Many studies have focused on MSCs from bone marrow or
adipose tissue, since they can easily be undifferentiated/
amplified in vitro, they are immunocompatible, and their use
is not ethically controversial. These MSCs represent a novel
means of repairing injured tissue through their proregenera-
tive, proangiogenic, and anti-inflammatory activity. Further-
more, therapeutic benefits for intestinal damage induced by
radiation or inflammation have been reported.28 Experi-
ments performed on animal models with colorectal damage
similar to that observed in patients developing severe side
effects after RT have shown that MSC treatment yields bet-
ter epithelial injury scores and limits fibrosis.47,48 In one
model of sutured gastric perforation, injection of MSCs
favored wound healing49; however, no report showing
Figure 4. (A) Representative pictures of colonoscopy analysis of each group and graph of the score obtained for n¼ 7 animals in each group.
(B) Table of evaluation of bleeding in each group during the colonoscopy (8 wk).
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enhanced healing following colonic anastomosis and irradia-
tion has been published. In this study, iterative Ad-MSC
treatment (3 injections) statistically reduced the size of the
ulcer scar measured on histological slides. Decreased hemor-
rhaging after colonoscopy was also observed. Similarly, pre-
clinical and clinical data have revealed that after severe
radiation damage, repeated injections of MSCs are needed
to improve wound healing.5,48 The substantial therapeutic
effects of MSCs may be attributed to the wide range of
substances they secrete.30 In previous studies, we demon-
strated that MSCs from bone marrow stimulate proliferation
of epithelial cells in colonic crypts near the ulcer, leading to
reduction in mucosal damage.47 Few MSCs were detected in
the damaged area, suggesting a therapeutic effect through
systemic action, probably induced by MSCs trapped in the
lung, as suggested by Prockop et al.50 In this study, although
some Ad-MSCs were locally injected, they were not detected
in the irradiated colon after anastomosis (data not provided).
As in our previous study, we believe that therapeutic benefit
is probably mediated by the stimulation of the secretion of
molecules by endogenous cells that enhance the endogenous
regenerative process.
Neovascularization permits tissue perfusion and oxyge-
nation, thereby playing a very important role in anastomotic
healing. However, irradiation leads to endothelial cell apop-
tosis, increased vascular dilatation and permeability, and
acquisition of a pro-inflammatory and procoagulant pheno-
type.51 These modifications strongly contribute to the devel-
opment and chronicity of radiation-induced injury. In this
study, we observed major bleeding after colonoscope inser-
tion in irradiated rats. This suggests that irradiation modifies
vessel structure. We also noted that, in irradiated and oper-
ated colons, the number of vascular sections after 8 wk was
lower than in sham animals (G1). However, after Ad-MSC
treatment, the number of vascular sections is comparable to
that in sham animals. Histological data demonstrated that
vessels detected are small, which may suggest induction of
neovascularization. In the small intestine, it has already been
already demonstrated that MSCs induce the formation of a
large number of microvessels associated with an increase in
VEGF gene expression.52 Together these results suggest an
improvement of the vascular compartment and greater qual-
ity and number of vessels after cell therapy. A better vascular
network may enhance the intake of growth factors and nutri-
ents, thus favoring the proregenerative process. However,
the Ad-MSC treatment did not induce complete epithelial
healing of colonic anastomosis as observed in nonirradiated
rats. This may be due to the animal model employed. This
study applied a single high dose of irradiation (29 Gy) to
the rat bowel. 47 This likely has a major effect on most
cells in the target area, resulting in a substantial loss of
regenerative potential and tissue integrity. In contrast, in
patients undergoing fractionated irradiation, some multi-
potent but quiescent cells in the crypt may survive irra-
diation and be available for tissue regeneration. Indeed, a
large body of data demonstrates that Ad-MSCs stimulate
Figure 5. (A) Representative histologic slides of colonic anastomosis
after irradiation stainedwithhematoxylin–eosin–saffron (HES).The size
of the atypia and ulcer was measured as mentioned by arrows on the
picture. (B)Graphofmean atypia and ulcer size normalizedwith irradia-
tionof each experiment (8wk). For each group, n¼ 7 animals; statistical
analysis of group 2 versus group 3was carried out usingMann-Whitney
test. (C) Analyses of vascularization process on histologic slides at 8wk.
Representativepicturesof vonWillebrand factor immunostaining (blue)
andnuclear fast redcounterstaining (pink). Thenumbersof vesselswere
counted using Histolab software, and results were report on the graph
(+ standard error of the mean [SEM]). For each group, n¼ 7 animals;
statistical analysis of group 2 versus group 3was carried out using t test.
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host endogenous tissue regeneration, offering greater ther-
apeutic benefit in regenerative animal models. Thus, it is
possible that our study employed an extreme animal
model and that Ad-MSCs would have been more thera-
peutic after fractionated irradiation. In previous labora-
tory studies, fractionated doses of irradiation (52 Gy in
4-Gy increments) did not induce epithelial damage53 as
observed in patients treated for rectal adenocarcinoma.47
In this study, the irradiation protocol-induced histological
damage similar to that observed in patients suffering
severe side effects after pelvic RT; it thus offers an
appropriate animal model.47 The results obtained are a
first step toward limiting irreversible ulceration after irra-
diation and colonic anastomosis.
The inflammatory process is essential to the initiation
of wound healing. However, it has been shown that per-
sistent inflammation is a feasible predictor of elevated
risk of colon anastomotic leakage.36 In this study, we
used 18F-FDG-PET/CT analysis to quantify inflammation.
In irradiated animals, we found that at the time of surgery
(4 wk after irradiation), the metabolic activity is in high
gear. However, in the group of rats that received 1 intra-
venous injection of Ad-MSCs, the inflammatory process
was more limited in extent, though this effect was not
observed at 8 wk. Analysis of macrophage infiltrates
revealed that after Ad-MSC treatment, the proportion of
M2 macrophages grew. It has already been demonstrated
that the prevention of colorectal anastomotic leakage is
associated with the presence of anti-inflammatory M2
macrophages.36 Taken as a whole, these findings suggest
that Ad-MSC treatment modifies the inflammatory pro-
cess, favoring the M2 phenotype and promoting wound
healing.
In conclusion, cell therapy using MSCs from adipose
tissue impedes radiation-induced injury and improves
colonic anastomotic healing after irradiation by enhanced
vascular supply and reduced inflammation. These results
suggest a possible role in the clinical prevention and
treatment of radiation-induced rectocolitis and anastomo-
tic healing in patients undergoing neoadjuvant RT. This
study demonstrates that MSC treatment has multithera-
peutic effects52 that could promote colonic anastomotic
Figure 6. (A) Representative images obtained with positron emission tomography–computed tomography (PET-CT) scan after intravenous
injection of a radioactive [18F]FDG tracer according to sagittal section (left panel), coronal section (middle panel), and transversal section
(right panel). The window of interest was designed, and the intensity of the signal (in Becquerel) was measured. (B) Graph of mean (+
standard error of the mean) Becquerel obtained in each groups at 4 and 8 wk. Statistics (4 wk) group 1 versus group 2, *P ¼ 0.03; group 1
versus group 3, P ¼ 0.16. Group 1: 4 wk; n ¼ 7; 8 wk; n ¼ 11. Group 2: 4 wk; n ¼ 18; 8 wk; n ¼ 8. Group 3: 4 wk; n ¼ 17; 8 wk; n ¼ 7.
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healing after irradiation. Though future developments,
such as shielding of injected cells in the irradiated area,54
may further enhance therapeutic effects, these results are
encouraging for the use of MSCs in regenerative
medicine.
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